Jakvinus - analogs
Components: Tofacitinib |
|||||||||
Pharmgroups: Immunosuppressants || Selective immunosuppressants |
|||||||||
| Prices in pharmacies: 397.6-981.8€ Instructions Jakvinus | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Atorvastatin ✘ (incl) Atorvastatin ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 83% — Relafen neutral [Nabumetone]
- 82% 18.9-19.6€ Leflaid Negative 🔍 [Leflunomide]
- 82% — Lefomide Negative 🔍 [Leflunomide]
- 81% 6.9-8.6€ Leflunomide Canon Negative 🔍 [Leflunomide]
- 81% 8.6-10.2€ Ehlafra Negative 🔍 [Leflunomide]
- 81% — Арресто Negative 🔍 [Leflunomide]
- 81% 8.2-9€ Leflunomide Negative 🔍 [Leflunomide]
- 79% 9.5-10.7€ Arava Negative 🔍 [Leflunomide]
- 74% 649.6€ Kevzara Negative 🔍 [Sarilumab]
- 74% 478.2€ Артлегиа Negative 🔍 [Olokizumab]
- 73% 321.8€ Тофара Negative 🔍 [Tofacitinib and more 1Aspartame]
- 69% 678.3-708.4€ Orensia Negative 🔍 [Abatacept]
- 69% — Tauredon Negative 🔍 [Sodium aurothiomalate]
- 66% 287.8-721.5€ Mabthera Negative 🔍 [Rituximab]
- 62% — Ранвэк Negative 🔍 [Upadacitinib]
- 56% — ИЛСИРА Negative 🔍 [Levilimab]
- 54% — Clofezone neutral [Clofezone]
- 52% 530€ Simponi Negative 🔍 [Golimumab]
- 50% — Bioline Arthritis neutral [Bryonia alba and more 7Cimicifuga racemosa, Rhus toxicodendron, Coffea cruda, Colchicum autumnale, Dulcamara, Apis mellifica, Rhododendron chrysanthum]
- 48% 10.7-10.9€ Ralef Negative 🔍 [Leflunomide]
- 48% — Byanodine Negative 🔍 [Penicillamine]
- 48% — Скайризи Negative 🔍 [Risankizumab]
- 48% 38-39.5€ Cuprenyl Negative 🔍 [Penicillamine]
- 48% — Пеницилламин-натив Negative 🔍 [Penicillamine]
- 47% — Sulfasalazin-nativ neutral [Sulfasalazine]
- 47% 3.8-4.7€ Sulfasalazin-EN neutral [Sulfasalazine]
- 47% 1.4-4.8€ Sulfasalazin neutral [Sulfasalazine]
- 46% 148.5€ Infliximab Negative 🔍 [Infliximab]
- 46% 150€ Фламмэгис Negative 🔍 [Infliximab]
- 46% 292.3€ Remicade Negative 🔍 [Infliximab]
- 45% 2.2€ Delagil Negative 🔍 [Chloroquine]
- 44% 41.7-42.1€ Thymodepressin neutral [Gamma-D-glutamyl-L-tryptophan]
- 43% 10.8€ Nobedolak neutral [Etodolac]
- 43% — Ревмакокс neutral [Celecoxib]
- 43% — Elderin neutral [Etodolac]
- 42% 5.3-6€ Sandimmun Dangerous 🔍 [Ciclosporin]
- 42% — Methylsalicylate liniment compositum neutral [Methylsalicylate]
- 42% — Methylsalicylate neutral [Methylsalicylate]
- 42% 2.9€ Cyclosporin Sandoz Dangerous 🔍 [Ciclosporin]
- 42% — Ciclopren Dangerous 🔍 [Ciclosporin]
- 42% 44.6-44.9€ Restasis Dangerous 🔍 [Ciclosporin]
- 41% — Эрелзи Negative 🔍 [Etanercept]
- 41% 194.8-385.8€ Этанерцепт ПСК Negative 🔍 [Etanercept]
- 41% — Кинерет Negative 🔍 [Anakinra]
- 41% 94.1-402.3€ Enbrel Negative 🔍 [Etanercept]
- 40% 1.4-4.3€ Celecoxib-VIAL neutral [Celecoxib]
- 40% 2.4-5.7€ Целекоксиб-ВЕРТЕКС neutral [Celecoxib]
- 40% 2.3-6.9€ Aflubin neutral [Aconitum napellus and more 4Bryonia alba, Ferrum phosphoricum, Gentiana lutea, Sarcolacticum acidum]
- 40% — Целексиб neutral [Celecoxib]
- 40% 2.9€ Roucoxib-Rowtech neutral [Celecoxib]
Learn more about the selection of analogues
- The drug has «Jakvinus» 2 full analogs, for example Тофацитиниб; 51 analog by action, the most similar - Leflaid (18.9-19.6€).
- Medical online service has selected the best substitutes for Jakvinus based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Jakvinus to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.